Related Experiment Videos

Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus

Gianpaolo Reboldi1, Giorgio Gentile, Fabio Angeli

  • 1Department of Internal Medicine, University of Perugia, Via E. Dal Pozzo, 06126 Perugia, Italy.

Expert Review of Cardiovascular Therapy
|November 11, 2009
PubMed

Insights

Managing hypertension in diabetics is crucial for preventing cardiovascular and kidney disease. Recent evidence suggests calcium channel blockers plus renin-angiotensin system blockers offer better outcomes than traditional diuretic combinations for hypertensive patients with diabetes.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Diabetes mellitus is a leading cause of mortality, primarily due to cardiovascular complications.
  • Hypertension exacerbates cardiovascular and renal risks in diabetic patients.
  • Achieving target blood pressure (<130/80 mmHg) in diabetics often requires multiple antihypertensive agents.

Purpose of the Study:

  • To review the evidence for optimal antihypertensive combination therapy in patients with diabetes mellitus and hypertension.
  • To compare the efficacy of novel drug combinations versus traditional diuretic-based regimens.
  • To explore improved cardiovascular, renal, and metabolic outcomes.

Main Methods:

  • Review of recent clinical trials and experimental evidence.
  • Comparative analysis of different antihypertensive drug combinations.
  • Focus on outcomes in patients with comorbid diabetes and hypertension.

Main Results:

  • Calcium channel blockers plus renin-angiotensin system blockers demonstrate superior cardiovascular and renal protection compared to diuretic-based combinations.
  • This newer combination also shows improved metabolic outcomes.
  • These findings challenge the previous consensus favoring diuretics in combination therapy.

Conclusions:

  • Combination therapy with calcium channel blockers and renin-angiotensin system blockers represents a potentially 'optimal' strategy for hypertensive diabetics.
  • This approach offers significant benefits in reducing cardiovascular events and preserving renal function.
  • Further research should confirm these advantages for long-term patient management.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...